Transcriptome profiling and characterization of peritoneal metastasis ovarian cancer xenografts in humanized mice by Sung Wan Kang, Ji-young Lee, Ok-Ju Kang, Yong-Man Kim, Eun Kyung Choi, Shin-Wha Lee

Get full text

Role of Neoadjuvant Chemotherapy in High-Grade Neuroendocrine Carcinoma of the Uterine Cervix by Hyerim Eum, Yoon-Kyung Shin, Ju-Hyun Kim, Yong Man Kim, Jong-Hyeok Kim, Dae-Shik Suh, Dae-Yeon Kim, Jeong-Yeol Park

Get full text

CD8α+ dendritic cells potentiate antitumor and immune activities against murine ovarian cancers by Shin-Wha Lee, Hyunah Lee, Kyung-Won Lee, Min-Je Kim, Sung Wan Kang, Young-Jae Lee, HyunSoo Kim, Yong-Man Kim

Get full text

Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer. by Sung Wan Kang, Ok-Ju Kang, Ji-Young Lee, Hyejeong Kim, Hunsoon Jung, Hongjoong Kim, Shin-Wha Lee, Yong Man Kim, Eun Kyung Choi

Get full text

The real-world efficacy and toxicity of first-line paclitaxel and cisplatin with bevacizumab in platinum-naïve primary stage IVB cervical cancer by Junhwan Kim, Eun-Byul Park, Shin-Wha Lee, Jeong-Yeol Park, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Ju-Hyun Kim

Get full text

296 HER2-specific highly scalable CAR NK cell (anti-HER2-CAR SNK02) exhibits a significantly enhanced antitumor activity against HER2-expressing tumors as an off-the-shelf allogene... by Yong Man Kim, Minji Kim, Yong-hee Rhee, Hee-Sung Chae, Seo-Gu Kang, Joungmin Lee, Yoon Mi Kang, Jae Seob Jung, Paul Y Song, Minchan Gil

Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko‐EVE) by Soseul Sung, Youjin Hong, Byoung‐Gie Kim, Ji‐Yeob Choi, Jae Weon Kim, Sang‐Yoon Park, Jae‐Hoon Kim, Yong‐man Kim, Jong‐Min Lee, Tae Jin Kim, Sue K. Park

Get full text

Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study by Clemente Humberto Zúñiga, Blanca Isaura Acosta, Rufino Menchaca, Cesar A. Amescua, Sean Hong, Lucia Hui, Minchan Gil, Yong-hee Rhee, Sangwook Yoon, Minji Kim, Paul Y. Chang, Yong Man Kim, Paul Y. Song, Katia Betito

Get full text

First‐In‐Human Dose Finding Study of Venadaparib (IDX‐1197), a Potent and Selective PARP Inhibitor, in Patients With Advanced Solid Tumors by Sung‐Bae Kim, Kyun‐Seop Bae, Jae Lyun Lee, Won Sik Lee, Chan‐Young Ock, Myong‐Jae Lee, Jeongsook Bang, Min Ju Hong, Eun‐Jihn Roh, Kyoung Soo Ha, Jong‐Ha Lim, Yong‐Man Kim

Get full text

Safety and efficacy of SNK01 (autologous natural killer cells) in combination with cytotoxic chemotherapy and/or cetuximab after failure of prior tyrosine kinase inhibitor in non-s... by Yong Man Kim, Gun Woo Son, Wonjun Ji, Mi Young Choi, Jae Seob Jung, Myeong Geun Choi, Jin Kyung Rho, Byeong Gon Yoon, Jong-Min Jo, Dae-Hyun Ko, Jae Cheol Lee, Chang-Min Choi

Get full text

GX-188E DNA vaccine plus pembrolizumab in HPV 16- and/or 18-positive recurrent or advance cervical cancer: a phase 2 trialResearch in context by Myong Cheol Lim, Youn Jin Choi, Soo-Young Hur, Yong-Man Kim, Jae Hong No, Byoung-Gie Kim, Chi Heum Cho, Sung Hoon Kim, Dae Hoon Jeong, Jae-Kwan Lee, Ji Hyun Kim, Yoon-Jeong Choi, Jung Won Woo, Young Chul Sung, Jong Sup Park

Get full text

Efficacy and safety of BVAC-C in HPV type 16- or 18–positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study by Chel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, Eun-Suk Kang, Duck Cho, Yong-Man Kim, Kidong Kim, Jae-Weon Kim, Hee Seung Kim, Young-Tae Kim, Jung-Yun Lee, Myong Cheol Lim, Taegwon Oh, Boyeong Song, Insu Jeon, Myunghwan Park, Wu Hyun Kim, Chang-Yuil Kang, Byoung-Gie Kim

Get full text